Lunella streamlines sleep apnea diagnosis
By HME News Staff
Updated Tue March 31, 2020
BOSTON - Lunella has launched today, allowing consumers to go through the entire process for a sleep apnea diagnosis from testing to a prescription for therapy if needed, all from their homes. Lunella leverages a collaboration with Itamar Medical and its FDA-cleared WatchPAT ONE to test for sleep apnea; and a network of independent board-certified sleep physicians to interpret confidential test data and prescribe therapy if needed. “We believe one of the biggest obstacles to diagnosing sleep apnea is convenience,” said Bob Wilkins, CEO of Lunella. “Lunella enables consumers to get easily diagnosed and helps them take those next critical steps toward treatment, all in a matter of days.” Using Lunella involves four steps: complete a free eight-question sleep apnea risk assessment at lunella.com, take the WatchPAT ONE single-use sleep apnea test at home, get a diagnosis from a board-certified sleep physician, and receive a prescription for the appropriate therapy if needed.
Comments